Revance

Revance Therapeutics, Inc. is a biopharmaceutical company dedicated to the development and commercialization of products and treatments for dermatology and aesthetic applications. Its product portfolio includes RT001, a botulinum toxin type A (BoNT-A) designed for physician-administered use in aesthetic procedures, hyperhidrosis, and dermatological indications.